A Dermatitis Control Program (DeCoP) for head and neck cancer patients receiving radiotherapy: a prospective phase II study.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 22350025)

Published in Int J Clin Oncol on February 15, 2012

Authors

Sadamoto Zenda1, Shinobu Ishi, Mitsuhiko Kawashima, Satoko Arahira, Makoto Tahara, Ryuichi Hayashi, Seiji Kishimoto, Tomiko Ichihashi

Author Affiliations

1: Division of Radiation Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. szenda@east.ncc.go.jp

Articles cited by this

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med (2003) 13.99

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med (2007) 10.06

Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med (2004) 9.55

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med (2004) 8.60

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med (2007) 7.05

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol (2003) 6.82

Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck (2005) 4.27

The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Cancer (2006) 2.22

State-of-the-art management of locally advanced head and neck cancer. Br J Cancer (2005) 1.80

Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radiother Oncol (2001) 1.30

Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. Br J Dermatol (2002) 1.22

Evidence-based skin care management in radiation therapy. Semin Oncol Nurs (2006) 1.20

The impact of skin washing with water and soap during breast irradiation: a randomized study. Radiother Oncol (2001) 0.92

Can patients wash during radiotherapy to the breast or chest wall? A randomized controlled trial. Clin Oncol (R Coll Radiol) (1992) 0.88

Skin treatment with bepanthen cream versus no cream during radiotherapy--a randomized controlled trial. Acta Oncol (1996) 0.86

Effects of Na-sucrose octasulfate on skin and mucosa reactions during radiotherapy of head and neck cancers--a randomized prospective study. Acta Oncol (2001) 0.84

Articles by these authors

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med (2015) 5.07

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial. Lancet Oncol (2013) 4.55

A phase I dose-escalation study of ZD6474 in Japanese patients with solid, malignant tumors. J Thorac Oncol (2006) 1.81

The best salvage operation method after total necrosis of a free jejunal graft? Transfer of a second free jejunal graft. J Plast Reconstr Aesthet Surg (2011) 1.55

Free vascularized nerve grafting for immediate facial nerve reconstruction. Laryngoscope (2005) 1.47

Bony eminence on the middle cranial fossa corresponding to the temporomandibular joint. Clin Anat (2007) 1.38

Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res (2004) 1.32

Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma. Cancer Sci (2013) 1.22

Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors. Cancer Sci (2008) 1.20

Long-term outcome of transoral organ-preserving pharyngeal endoscopic resection for superficial pharyngeal cancer. Gastrointest Endosc (2011) 1.18

Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Clin Oncol (2002) 1.18

Prospective study of early detection of pharyngeal superficial carcinoma with the narrowband imaging laryngoscope. Head Neck (2009) 1.12

Multi-institutional analysis of solitary extramedullary plasmacytoma of the head and neck treated with curative radiotherapy. Int J Radiat Oncol Biol Phys (2011) 1.11

A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancer. Am J Clin Oncol (2007) 1.07

Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys (2010) 1.05

Surgical management of carcinoma of the cervical esophagus. J Surg Oncol (2007) 1.05

Effect of RECIST revision on classification of target lesions and overall response in advanced gastric cancer patients. Gastric Cancer (2012) 1.04

Successful management of solitary malar metastasis from lung cancer. Lung Cancer (2002) 1.04

Amrubicin for the treatment of neuroendocrine carcinoma of the gastrointestinal tract: a retrospective analysis of five cases. Cancer Chemother Pharmacol (2011) 1.03

Pulmonary tumor thrombotic microangiopathy associated with esophageal squamous cell carcinoma. Intern Med (2011) 1.02

Carcinoma showing thymus-like differentiation (CASTLE) with neuroendocrine differentiation. Pathol Int (2008) 1.02

Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.02

Salvage surgery for recurrent oropharyngeal cancer after chemoradiotherapy. Int J Clin Oncol (2012) 1.02

Histopathological examination of ruptured carotid artery after irradiation. ORL J Otorhinolaryngol Relat Spec (2002) 1.01

A case of myoepithelioma arising in an accessory parotid gland. J Laryngol Otol (2002) 0.99

Neck node metastasis after successful brachytherapy for early stage tongue carcinoma. Radiother Oncol (2003) 0.99

Proton-beam therapy for olfactory neuroblastoma. Int J Radiat Oncol Biol Phys (2007) 0.98

Proton beam therapy as a nonsurgical approach to mucosal melanoma of the head and neck: a pilot study. Int J Radiat Oncol Biol Phys (2010) 0.98

Extrahepatic portal vein occlusion without recurrence after pancreaticoduodenectomy and intraoperative radiation therapy. Int J Radiat Oncol Biol Phys (2005) 0.97

Carcinoma coexisting with esophageal leiomyoma. Gastrointest Endosc (2002) 0.96

Dummy run for a phase II multi-institute trial of chemoradiotherapy for unresectable pancreatic cancer: inter-observer variance in contour delineation. Anticancer Res (2007) 0.96

Analysis of the relations between the shape of the reconstructed tongue and postoperative functions after subtotal or total glossectomy. Laryngoscope (2003) 0.96

Parapharyngeal space tumors: anatomical and image analysis findings. Auris Nasus Larynx (2010) 0.95

Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trial. Jpn J Clin Oncol (2013) 0.94

Velopharyngeal function after microsurgical reconstruction of lateral and superior oropharyngeal defects. Laryngoscope (2002) 0.93

Late laryngo-tracheal cartilage necrosis with external fistula 44 years after radiotherapy. J Laryngol Otol (2003) 0.92

Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia. Jpn J Clin Oncol (2011) 0.91

Altered carbohydrate metabolism in the storage roots of sweet potato plants overexpressing the SRF1 gene, which encodes a Dof zinc finger transcription factor. Planta (2009) 0.91

Nasopharyngeal pleomorphic adenoma presenting as otitis media with effusion: case report and literature review. Am J Otolaryngol (2013) 0.91

Window resection of the trachea and secondary reconstruction for invasion by differentiated thyroid carcinoma. Auris Nasus Larynx (2010) 0.90

Lipoma in the deep lobe of the parotid gland: a case report. Auris Nasus Larynx (2002) 0.90

Simple maxillary reconstruction using free tissue transfer and prostheses. Plast Reconstr Surg (2003) 0.90

Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck. Cancer Sci (2010) 0.90

Adverse hepatic events caused by radiotherapy for advanced hepatocellular carcinoma. J Gastroenterol Hepatol (2005) 0.90

Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice. Cancer Sci (2008) 0.90

Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma. Int J Clin Oncol (2014) 0.89

Nonplatinum-based chemotherapy with irinotecan plus docetaxel for advanced or metastatic olfactory neuroblastoma: a retrospective analysis of 12 cases. Cancer (2008) 0.89

A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer. Cancer Chemother Pharmacol (2009) 0.89

High expression level of geminin predicts a poor clinical outcome in salivary gland carcinomas. Histopathology (2010) 0.89

Reliability of and indications for pericranial flaps in anterior skull base reconstruction. J Craniofac Surg (2011) 0.88

A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy. Cancer Chemother Pharmacol (2010) 0.88

A new concept for classifying skull base defects for reconstructive surgery. J Neurol Surg B Skull Base (2012) 0.88

Non-surgical approach to small cell carcinoma of the esophagus: does this rare disease have the same tumor behavior as SCLC? Int J Clin Oncol (2011) 0.88

Evaluation of cartilage invasion by laryngeal and hypopharyngeal squamous cell carcinoma with dual-energy CT. Radiology (2012) 0.88

Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck. Jpn J Clin Oncol (2013) 0.87

Treatment strategy for superficial pharyngeal squamous cell carcinoma synchronously combined with esophageal cancer. Oncology (2012) 0.87

Feasibility study of single agent Cisplatin and concurrent radiotherapy in Japanese patients with squamous cell carcinoma of the head and neck: preliminary results. Jpn J Clin Oncol (2007) 0.86

Accelerated radiotherapy for T1 to T2 glottic cancer. Head Neck (2014) 0.86

Mucosal defect repair with a polyglycolic acid sheet. Jpn J Clin Oncol (2012) 0.86

Prospective study of positron emission tomography for evaluation of the activity of lapatinib, a dual inhibitor of the ErbB1 and ErbB2 tyrosine kinases, in patients with advanced tumors. Jpn J Clin Oncol (2006) 0.86

Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma. Cancer (2003) 0.86

The role of pulmonary resection in tumors metastatic from head and neck carcinomas. Jpn J Clin Oncol (2010) 0.85

Angiolymphoid hyperplasia with eosinophilia arising from the facial artery. J Laryngol Otol (2003) 0.85

Partial maxillary swing approach for removal of the tumors in the retromaxillary area. Auris Nasus Larynx (2009) 0.85

Apparent absence of a proton beam dose rate effect and possible differences in RBE between Bragg peak and plateau. Med Phys (2010) 0.84

Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy. Radiother Oncol (2011) 0.84

Trimodal combination therapy for maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys (2002) 0.84

Efficient screening of long terminal repeat retrotransposons that show high insertion polymorphism via high-throughput sequencing of the primer binding site. Genome (2014) 0.84

A comparison of perioperative complications following transfer of fibular and scapular flaps for immediate mandibular reconstruction. J Plast Reconstr Aesthet Surg (2012) 0.83

Statistical analysis of surgical site infection after head and neck reconstructive surgery. Ann Surg Oncol (2014) 0.83

Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan. Jpn J Clin Oncol (2009) 0.83

Giant malignant insulinoma which developed from a non-functioning pancreatic tumor over a long period of time. Intern Med (2010) 0.83

A LINE-type retrotransposon active in meristem stem cells causes heritable transpositions in the sweet potato genome. Plant Mol Biol (2006) 0.83

Application of the fecal microRNA test to the residuum from the fecal occult blood test. Jpn J Clin Oncol (2013) 0.83

Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients. Cancer Sci (2006) 0.83

Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys (2010) 0.83

The effectiveness of chemoradiation therapy and salvage surgery for hypopharyngeal squamous cell carcinoma. Jpn J Clin Oncol (2013) 0.83

Current role of the iliac crest flap in mandibular reconstruction. Microsurgery (2011) 0.82

Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancer. Int J Clin Oncol (2008) 0.82

Functional reconstruction with free flaps following ablation of oropharyngeal cancer. Int J Clin Oncol (2005) 0.82

Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy. BMC Cancer (2014) 0.82

Usability of the middle temporal vein as a recipient vessel for free tissue transfer in skull-base reconstruction. Ann Plast Surg (2012) 0.82

Measurement of the facial nerve caliber in facial palsy: implications for facial nerve decompression. Otol Neurotol (2011) 0.82

Larynx-preserving esophagectomy and jejunal transfer for cervical esophageal carcinoma. Laryngoscope (2009) 0.81